Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06971458

Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol

Sponsor: Hillel Yaffe Medical Center

View on ClinicalTrials.gov

Summary

Ovarian endometriomas are cystic masses lined with endometrial tissue that contains fluid arising from a collection of menstrual debris. Ovarian endometriomas clinical manifestations includes pelvic pain, dysmenorrhea, dysfunctional uterine bleeding, and infertility. Endometriomas are most commonly treated either medically or by surgical excision. Ultrasonography (US)-guided aspiration and sclerotherapy is a new approach. Its mechanism of action is believed to be destruction of the inner epithelial lining, which is followed by inflammation and fibrosis, eventually resulting in regression of the cyst. The main advantage in this approach is the avoidance of collateral damage to the ovary.

Official title: Endometrioma Ethanol Sclerotherapy and Its Effect on Ovarian Function and Fertility Treatment Outcome - Prospective Cohort Study Protocol

Key Details

Gender

FEMALE

Age Range

18 Years - 41 Years

Study Type

OBSERVATIONAL

Enrollment

120

Start Date

2022-08-09

Completion Date

2027-12-31

Last Updated

2025-05-14

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Sclerotherapy

ultrasound (US)-guided sclerotherapy for the treatment of ovarian endometrioma

Locations (1)

Hillel Yaffe Medical Center

Hadera, Israel